The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Risk factors for age-related macular degeneration
Abstract
Objective To assess the prevalence and potential risk factors for late age-related macular degeneration (AMD) in three racially similar populations from North America, Europe, and AUSTRALIA:Design Combined analysis of population-based eye disease prevalence data.Participants There were 14,752 participants with gradable photographs from the Beaver Dam Eye Study (n = 4756), Rotterdam Study (n = 6411), and Blue Mountains Eye Study (n = 3585).Main outcome measures AMD diagnosis was made from masked grading of stereo macular photographs. Final classification of AMD cases was agreed by consensus between study investigators.Results AMD prevalence was strongly age related. Overall, AMD was present in 0.2% of the combined population aged 55 to 64 years, rising to 13% of the population older than 85 years. Prevalence of neovascular AMD (NV) increased from 0.17% among subjects aged 55 to 64 years to 5.8% for those older than 85 years. Prevalence of pure geographic atrophy (GA) increased from 0.04% to 4.2% for these age groups. There were no significant gender differences in the prevalence of NV or GA. Subjects in the Rotterdam population had a significantly lower age-adjusted and smoking-adjusted risk of NV than subjects in the Beaver Dam and Blue Mountains populations. Apart from age, tobacco smoking was the only risk factor consistently associated with any form of AMD in all sites separately and in pooled analyses over the three sites.Conclusions These combined data from racially similar communities across three continents provide strong and consistent evidence that tobacco smoking is the principal known preventable exposure associated with any form of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In total, data from 18 prospective, cross-sectional studies and 8 case control studies [12,24-26,28,30,31,33-47,49-54,57-73] were included in the final analysis, contributing a sample of some 94,058 patients (ranging from 261 to 22,071) including 3,178 (ranging from 8 to 776) late AMD cases.”
From Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis (2010) · cites this paper as [25]
In the citing paper
“Age is the strongest risk factor associated with the development of AMD (3, 112, 140) (Figure 3).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [140]
In the citing paper
“The pooled data from two population-based studies reveal an estimated prevalence of advanced AMD of ~0.2% in ages 55 to 64, increasing to 13% in those older than 85 years (140).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [140]
In the citing paper
“Female sex may be a risk factor in individuals aged over 75 years,16 with the relative risk for neovascular age-related macular degeneration in women possibly as much as twice that observed in age-matched men.”
From Age-related macular degeneration (2008) · cites this paper as [16]
In the citing paper
“These three large population-based studies have found that the incidence of advanced age-related macular degeneration increases with age, as does the development of large drusen and pigmentary changes.”
From Age-related macular degeneration (2008) · cites this paper as [16]
In the citing paper
“Data pooled from three population-based studies—the Beaver Dam Eye Study, the Rotterdam Study, and the Blue Mountains Eye Study—have estimated the prevalence of advanced age-related macular degeneration to be 0·2% in those aged 55–64 years, increasing to 13% in those older than 85 years.16”
From Age-related macular degeneration (2008) · cites this paper as [16]
Citations
Cites
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Self-citationPrevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
Self-citationKlein, R., Klein, R., Moss, S. E., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)32011-1 · Cited by 1,382
Self-citationLeibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
The Wisconsin Age-related Maculopathy Grading System
Klein, R., Davis, M. D., Magli, Y. L., Segał, P., Klein, R., & Hubbard, L. D. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32186-9 · Cited by 1,188
Self-citationThe Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, R., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,154
Self-citationPrevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Self-citationThe Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Drusen and Disciform Macular Detachment and Degeneration
Gass, J. D. M. (1973) · Archives of Ophthalmology · doi:10.1001/archopht.1973.01000050208006 · Cited by 593
Senile macular degeneration: a case-control study
HYMAN, L. G., LILIENFELD, A. M., FERRIS, F. L., & FINE, S. L. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113629 · Cited by 587
Cited by
Sorted by citations
Items 301–400 of 1,000
Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Bocci, V. A., Zanardia, I., Valacchi, G., Borrelli, E., & Travagli, V. (2015) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x1502151209114642 · Cited by 55
Prevalence of Age-Related Macular Degeneration in Australia
Keel, S., Xie, J., Foreman, J., van Wijngaarden, P., Taylor, H. R., & Dirani, M. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.4182 · Cited by 55
Vascular endothelial growth factors in retinal and choroidal neovascular diseases
Kinnunen, K., & Ylä‐Herttuala, S. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.532150 · Cited by 53
Klein, R. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.534 · Cited by 53
Self-citationTanimoto, S., Tamura, H., Ue, T., Yamane, K., Maruyama, H., Kawakami, H., & Kiuchi, Y. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.011 · Cited by 53
Thyroid Dysfunction and Ten-Year Incidence of Age-Related Macular Degeneration
Gopinath, B., Liew, G., Kifley, A., & Mitchell, P. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19735 · Cited by 52
Self-citationXu, Q., Cao, S., Rajapakse, S., & Matsubara, J. A. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-017-0647-7 · Cited by 52
Palkovits, S., Hirnschall, N. D., Georgiev, S., Leisser, C., & Findl, O. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.1.17 · Cited by 52
Wu, K. H. C., Tan, A. G., Rochtchina, E., Favaloro, E. J., Williams, A., Mitchell, P., & Wang, J. J. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0223 · Cited by 53
Self-citationCheung, C. M. G., Li, X., Cheng, C., Zheng, Y., Mitchell, P., Wang, J. J., Jonas, J. B., Nangia, V. B., & Wong, T. Y. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.10.013 · Cited by 51
Self-citationvan Grinsven, M. J. J. P., Lechanteur, Y. T. E., van de Ven, J. P. H., van Ginneken, B., Hoyng, C. B., Theelen, T., & Sánchez, C. I. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11449 · Cited by 52
Inflammatory Markers in Age-Related Maculopathy
Dasch, B. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1501 · Cited by 51
Roberts, P. K., Sugita, M., Deák, G. G., Baumann, B., Zotter, S., Pircher, M., Sacu, S., Hitzenberger, C. K. F., & Schmidt-Erfurth, U. M. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18694 · Cited by 51
Paun, C. C., Ersoy, L., Schick, T., Groenewoud, J. M. M., Lechanteur, Y. T. E., Fauser, S., Hoyng, C. B., de Jong, E. K., & den Hollander, A. I. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17035 · Cited by 51
Wang, H., Wittchen, E. S., Jiang, Y., Ambati, B. K., Grossniklaus, H. E., & Hartnett, M. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8230 · Cited by 51
Sparing of age-related macular degeneration in rheumatoid arthritis
McGeer, P. L., & Sibley, J. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.003 · Cited by 51
Oliver-Fernandez, A., Bakal, J., Segal, S., Shah, G. K., Dugar, A., & Sharma, S. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80074-2 · Cited by 50
CHANG, M. A., Bressler, S. B., Muñoz, B. E., & West, S. K. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1584 · Cited by 54
Johnson, E., Dominici, F., Griswold, M. E., & Zeger, S. L. (2002) · Journal of Econometrics · doi:10.1016/s0304-4076(02)00157-4 · Cited by 50
Older men's experiences of living with severe visual impairment
Moore, L. W., & Miller, M. (2003) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2003.02668.x · Cited by 49
Owsley, C. J., Clark, M. E., & McGwin, G. (2017) · Translational Vision Science & Technology · doi:10.1167/tvst.6.3.15 · Cited by 49
Prevention of the Onset of Age-Related Macular Degeneration
Carlo, E. D., & Augustin, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153297 · Cited by 48
Lai, T. Y. Y., & Fong, A. H. C. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s36811 · Cited by 50
Five-year change in visual acuity and incidence of visual impairment
Foran, S., Mitchell, P., & Wang, J. J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01295-2 · Cited by 48
Self-citationDeAngelis, M. M. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.575 · Cited by 48
Gene expression variation in the adult human retina
Chowers, I., Liu, D., Farkas, R. H., Gunatilaka, T. L., Hackam, A. S., Bernstein, S. L., Campochiaro, P. A., Parmigiani, G., & Zack, D. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg326 · Cited by 48
Montes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47
Caire, J., Recalde, S., Velázquez-Villoria, Á., García‐García, L., Reiter, N., Anter, J., Fernández‐Robredo, P., & García‐Layana, A. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.8175 · Cited by 47
Risk Factors for Age-Related Maculopathy
Connell, P., Keane, P. A., O’Neill, E. C., Al‐Taie, R., Loane, E., Neelam, K., Nolan, J. M., & Beatty, S. (2009) · Journal of Ophthalmology · doi:10.1155/2009/360764 · Cited by 49
Ishibashi, K., Tian, J. Y., & Handa, J. T. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0168 · Cited by 47
Li, Q., Dinculescu, A., Shan, Z. J., Miller, R. C., Pang, J., Lewin, A. S., Raizada, M. K., & Hauswirth, W. W. (2008) · Molecular Therapy · doi:10.1038/mt.2008.164 · Cited by 47
Naj, A. C., Scott, W. K., Courtenay, M. D., Cade, W. H., Schwartz, S. G., Kovach, J. L., Agarwal, A., Wang, G., Haines, J. L., & Pericak‐Vance, M. A. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12011 · Cited by 47
Corominas, J., Colijn, J. M., Geerlings, M. J., Pauper, M., Bakker, B., Amin, N., Lorés‐Motta, L., Kersten, E., Garanto, A., Verlouw, J., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.03.040 · Cited by 46
Self-citationWang, J. J. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.88.1.104 · Cited by 46
Self-citationEsumi, N., Kachi, S., Campochiaro, P. A., & Zack, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609517200 · Cited by 47
Lyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45
Prevalence and Risks Factors of Age-Related Macular Degeneration in Oklahoma Indians
Butt, A. L., Lee, E. T., Klein, R., Russell, D., Ogola, G., Warn, A. A., Kingsley, R. M., & Yeh, J. L. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.11.007 · Cited by 45
Self-citationLi, Y., Zou, X., Cao, K. J., Xu, J., Yue, T., Dai, F., Zhou, B., Lu, W., Feng, Z., & Liu, J. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.07.029 · Cited by 45
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration
Čolak, E., Majkić‐Singh, N., Zoric, L. D., Radosavljević, A., & Kosanović-Jaković, N. (2012) · Biochemia Medica · doi:10.11613/bm.2012.005 · Cited by 46
Shirinifard, A., Glazier, J. A., Swat, M., Gens, J. S., Family, F., Jiang, Y., & Grossniklaus, H. E. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002440 · Cited by 45
Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular Degeneration
Songstad, A. E., Wiley, L. A., Duong, K., Kaalberg, E. E., Flamme‐Wiese, M. J., Cranston, C. M., Riker, M. J., Levasseur, D. N., Stone, E. M., Mullins, R. F., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17073 · Cited by 45
He, H., Wei, D., Liu, H., Zhu, C. Y., Lu, Y. P., Ke, Z., Jiang, S., & Huang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14246 · Cited by 45
Hosoda, Y., Miyake, M., Yamashiro, K., Ooto, S., Takahashi, A., Oishi, A., Miyata, M., Uji, A., Muraoka, Y., & Tsujikawa, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75451-5 · Cited by 45
Priore, L. V. D., Tezel, T. H., & KAPLAN, H. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.08.001 · Cited by 45
Pan, Y., Fu, Y., Baird, P. N., Guymer, R. H., Das, T., & Iwata, T. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101159 · Cited by 47
Biswal, M. R., Ahmed, C. M. I., Ildefonso, C. J., Han, P., Li, H., Jivanji, H., Mao, H., & Lewin, A. S. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.022 · Cited by 46
Pfister, G., & Savino, W. (2008) · NeuroImmunoModulation · doi:10.1159/000156477 · Cited by 44
Kim, T.-H., Wang, B., Lu, Y., Son, T., & Yao, X. (2020) · Biomedical Optics Express · doi:10.1364/boe.399334 · Cited by 43
Gupta, O. P. (2009) · Evidence-Based Ophthalmology · doi:10.1097/ieb.0b013e31819201e5 · Cited by 43
Alcazar, O., Cousins, S. W., & Marin-Castan~o, M. E. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0392 · Cited by 43
Circulating Hematopoietic Stem Cells in Patients with Neovascular Age-Related Macular Degeneration
Yodoi, Y., Sasahara, M., Kameda, T., Yoshimura, N., & Otani, A. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0093 · Cited by 43
Leveziel, N., Zerbib, J., Richard, F., Querques, G., Morineau, G., Frémeaux‐Bacchi, V., COSCAS, G. J., Soubrane, G., Benlian, P., & Souied, E. H. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1540 · Cited by 43
Retinal Photodamage by Endogenous and Xenobiotic Agents†
Wielgus, A. R., & Roberts, J. E. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01174.x · Cited by 44
Fang, I., Yang, C., Yang, C.-M., & Chen, M. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.09.019 · Cited by 43
Protein localization in the human eye and genetic screen of opticin
Friedman, J. S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1333 · Cited by 43
Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium
Delcourt, C., Korobelnik, J., Buitendijk, G. H. S., Foster, P. J., Hammond, C. J., Piermarocchi, S., Pető, T., Jansonius, N. M., Mirshahi, A., Hogg, R. E., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0098-2 · Cited by 42
Self-citationReview of the association between retinal microvascular characteristics and eye disease
Newman, A. R., Andrew, N. H., & Casson, R. J. (2017) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13119 · Cited by 42
Serum levels of macular carotenoids in relation to age-related maculopathy
Dasch, B., Fuhs, A., Schmidt, J. G. H., Behrens, T., Meister, A., Wellmann, J., Fobker, M., Pauleikhoff, D., & Hense, H. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-1176-z · Cited by 42
Sex steroids and age-related macular degeneration in older French women: the POLA study
Defay, R., Pinchinat, S., Lumbroso, S., Sutan, C., Delcourt, C., & The Pola Study Group (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00130-3 · Cited by 42
Complement Regulatory Protein CD46 Protects against Choroidal Neovascularization in Mice
Lyzogubov, V., Wu, X., Jha, P., Tytarenko, R., Triebwasser, M., Kolar, G., Bertram, P., Bora, P. S., Atkinson, J. P., & Bora, N. S. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.06.001 · Cited by 41
Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 42
Brandl, C., Breinlich, V., Stark, K. J., Enzinger, S., Aßenmacher, M., Olden, M., Graßmann, F., Graw, J., Heier, M., Peters, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167181 · Cited by 45
Edwards, D. R. V., Gallins, P. J., Polk, M., Ayala-Haedo, J., Schwartz, S. G., Kovach, J. L., Spencer, K., Wang, G., Agarwal, A., Postel, E. A., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4000 · Cited by 42
Mitotropic Compounds for the Treatment of Age-Related Macular Degeneration
Fehér, J., Papale, A., Mannino, G., Gualdi, L., & Gabrieli, C. B. (2003) · Ophthalmologica · doi:10.1159/000071351 · Cited by 41
Taylor, H. R. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0571 · Cited by 41
Genome-wide analysis of copy number variants in age-related macular degeneration
Meyer, K. J., Davis, L. K., Schindler, E. I., Beck, J. S., Rudd, D. S., Grundstad, A. J., Scheetz, T. E., Braun, T. A., Fingert, J. H., Alward, W. L. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0904-6 · Cited by 42
La, T. Y., Cho, E., Kim, E. C., Kang, S., & Jee, D. (2014) · Current Eye Research · doi:10.3109/02713683.2014.907431 · Cited by 41
AMD-like retinopathy associated with intravenous iron
Song, D., Kanu, L. N., Li, Y., Kelly, K. L., Bhuyan, R. K., Alemán, T. S., Morgan, J. I. W., & Dunaief, J. L. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.08.008 · Cited by 40
A Novel Pro-Angiogenic Function for Interferon-γ–Secreting Natural Killer Cells
Lee, H., Schlereth, S. L., Park, E. Y., Emami-Naeini, P., Chauhan, S. K., & Dana, R. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14093 · Cited by 40
Costs of Interventions for Visual Impairment
Taylor, H. R., Pezzullo, M. L., Nesbitt, S. J., & Keeffe, J. E. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.10.055 · Cited by 41
Molecular Genetic Mechanisms in Age-Related Macular Degeneration
Shughoury, A., Sevgi, D. D., & Ciulla, T. A. (2022) · Genes · doi:10.3390/genes13071233 · Cited by 42
Role of Flicker Perimetry in Predicting Onset of Late-Stage Age-Related Macular Degeneration
Luu, C. D., Dimitrov, P. N., Robman, L. D., Varsamidis, M., Makeyeva, G. A., Aung, K.-Z., Vingrys, A. J., & Guymer, R. H. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2012.277 · Cited by 39
Hadley, D., Orlin, A., Brown, G. C., Brucker, A. J., Ho, A. C., Regillo, C. D., Donoso, L. A., Tian, L., Kaderli, B., & Stambolian, D. E. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3798 · Cited by 40
Update on clinical trials in dry Age-related macular degeneration
Schatz, P., Taşkintuna, İ., & Elsayed, M. E. A. A. (2016) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.173134 · Cited by 40
Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option
Ashraf, M., & Souka, A. (2017) · Eye · doi:10.1038/eye.2017.81 · Cited by 39
Cheong, K. X., Teo, K. Y. C., & Cheung, C. M. G. (2020) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.05.003 · Cited by 39
Bergman, B., Nilsson‐Ehle, H., & Sjöstrand, J. (2004) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2004.00182.x · Cited by 39
Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration
Adamus, G., Chew, E. Y., Ferris, F. L., & Klein, M. L. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-154 · Cited by 42
Zhao, L., Grob, S., Avery, R. L., KIMURA, A. E., Pieramici, D. J., Lee, J., Rabena, M., Ortiz, S. O., Quach, J., Cao, G., et al. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990048 · Cited by 39
Age-related Macular Degeneration and Complement Activation–related Diseases
Nitsch, D., Douglas, I., Smeeth, L. L., & FLETCHER, A. E. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.035 · Cited by 39
Laser treatment of drusen to prevent progression to advanced age-related macular degeneration
Parodi, M. B., Virgili, G., & Evans, J. R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006537.pub2 · Cited by 39
The Potential Role of Dietary Antioxidant Capacity in Preventing Age-Related Macular Degeneration
Arslan, S., Kadayıfçılar, S., & Samur, G. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1538830 · Cited by 38
Yip, J. L. Y., Khawaja, A. P., Chan, M. P. Y., Broadway, D. C., Pető, T., Tufail, A., Luben, R., Hayat, S. A., Bhaniani, A., Wareham, N. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132565 · Cited by 38
Long-term Changes in Visual Acuity in an Older Population over a 15-Year Period
Hong, T., Mitchell, P. L. R., Rochtchina, E., Fong, C. S., Chia, E., & Wang, J. J. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.032 · Cited by 38
Self-citationChuo, J. Y., Wiens, M. O., Etminan, M., & Maberley, D. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580701421684 · Cited by 38
Prevalence of Age-Related Macular Degeneration in Portugal: The Coimbra Eye Study - Report 1
Cachulo, M. L., Lobo, C. L., Figueira, J., Ribeiro, L., Laíns, I., Vieira, A., Nunes, S. G., Costa, M. A., Simão, S., Rodrigues, V., et al. (2015) · Ophthalmologica · doi:10.1159/000371584 · Cited by 38
Prevalence of age-related macular degeneration in Spain
Spanish Eyes Epidemiological (SEE) Study Group (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.187773 · Cited by 40
Fraser‐Bell, S., Donofrio, J., Wu, J., Klein, R., Azen, S. P., & Varma, R. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.08.029 · Cited by 40
Self-citationPredicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
van Asten, F., Rovers, M. M., Lechanteur, Y. T. E., Smailhodzic, D., Muether, P. S., Chen, J., den Hollander, A. I., Fauser, S., Hoyng, C. B., van der Wilt, G. J., et al. (2014) · Ophthalmic Epidemiology · doi:10.3109/09286586.2014.949010 · Cited by 37
Boltz, A., Ruiß, M., Jonas, J. B., Tao, Y. K., Rensch, F., Weger, M., Garhöfer, G., Frantal, S., El‐Shabrawi, Y., & Schmetterer, L. F. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.001 · Cited by 37
Asian Age-Related Macular Degeneration
Lim, L. S., Cheung, C. M. G., & Wong, T. Y. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31827ff5bc · Cited by 37
Jackson, G. R., McGwin, G., Phillips, J. M., Klein, R., & Owsley, C. J. (2005) · Vision Research · doi:10.1016/j.visres.2005.09.003 · Cited by 37
Self-citationAnalysis of the EFEMP1 gene in individuals and families with early onset drusen
Narendran, N., Guymer, R. H., Cain, M. S., & Baird, P. N. (2004) · Eye · doi:10.1038/sj.eye.6701435 · Cited by 37
Statin Use and the Risk of Age Related Macular Degeneration in a Large Health Organization in Israel
Shalev, V., Sror, M., Goldshtein, I., Kokia, E. S., & Chodick, G. (2011) · Ophthalmic Epidemiology · doi:10.3109/09286586.2011.560746 · Cited by 38
Age‐Related Macular Degeneration: A Practical Approach to a Challenging Disease
Bourla, D. H., & Young, T. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00771.x · Cited by 37
Sheth, J. U., Stewart, M. W., Narayanan, R., Anantharaman, G., Chandran, K., Lai, T. Y. Y., Chakravarthy, U., & Das, T. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.08.003 · Cited by 36
Angiotensin II-related hypertension and eye diseases
Marín‐García, P. J. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.968 · Cited by 37
Update on Geographic Atrophy in Age‐Related Macular Degeneration
Biarnés, M., Monés, J., Alonso, J., & Arias, L. (2011) · Optometry and Vision Science · doi:10.1097/opx.0b013e31821988c1 · Cited by 37
Seixas, A. A., Trinh‐Shevrin, C., Ravenell, J. E., Ogedegbe, G. G., Zizi, F., & Jean‐Louis, G. (2018) · Trials · doi:10.1186/s13063-018-2835-9 · Cited by 36
Metadata
- Authors
- Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M.
- Affiliations
- Australian National University (AU)
- Erasmus University Rotterdam (NL)
- The University of Sydney (AU)
- University of Wisconsin–Madison (US)
- Corresponding author
- Mitchell, Paul
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2001-04
- Volume
- 108
- Issue
- 4
- Pages
- 697-704
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W1543801259
- Cited by
- 1,071
- References
- 43
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 43 · 2023: 33 · 2022: 44 · 2021: 51 · 2020: 30 · 2019: 28 · 2018: 33 · 2017: 43 · 2016: 43 · 2015: 46 · 2014: 70 · 2013: 52 · 2012: 60
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, neovascular AMD, geographic atrophy, prevalence, risk factors, smoking, age, gender differences, Beaver Dam Eye Study, Rotterdam Study, Blue Mountains Eye Study, cross-population comparison
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Macular Degeneration, Male, Middle Aged, Netherlands, New South Wales, Risk Factors, Smoking, Wisconsin, Prevalence, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
